GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (FRA:QIA) » Definitions » Equity-to-Asset

Qiagen NV (FRA:QIA) Equity-to-Asset : 0.62 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Qiagen NV's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €3,492 Mil. Qiagen NV's Total Assets for the quarter that ended in Dec. 2023 was €5,608 Mil. Therefore, Qiagen NV's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.62.

The historical rank and industry rank for Qiagen NV's Equity-to-Asset or its related term are showing as below:

FRA:QIA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.46   Med: 0.53   Max: 0.62
Current: 0.62

During the past 13 years, the highest Equity to Asset Ratio of Qiagen NV was 0.62. The lowest was 0.46. And the median was 0.53.

FRA:QIA's Equity-to-Asset is ranked better than
53.56% of 239 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs FRA:QIA: 0.62

Qiagen NV Equity-to-Asset Historical Data

The historical data trend for Qiagen NV's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Equity-to-Asset Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.48 0.50 0.55 0.62

Qiagen NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.57 0.57 0.63 0.62

Competitive Comparison of Qiagen NV's Equity-to-Asset

For the Diagnostics & Research subindustry, Qiagen NV's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Equity-to-Asset falls into.



Qiagen NV Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Qiagen NV's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=3491.72/5607.629
=0.62

Qiagen NV's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=3491.72/5607.629
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qiagen NV  (FRA:QIA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Qiagen NV Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV (FRA:QIA) Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Executives
Dr. Metin Colpan Supervisory Board

Qiagen NV (FRA:QIA) Headlines

No Headlines